AccessPD is a next generation research database and tissue bank (RTB) to advance our understanding of Parkinson’s Disease and accelerate the development of advanced therapies to improve outcomes for patients.
AccessPD
Annual burden of Parkinson's Disease in the UK:
£0million
Annual cost to the NHS
0
Hospitalisations
0
Predicted to be diagnosed by 2030
Key Study Information:
-
Treatment Area:
Parkinson's Disease
-
Study Type:
Ongoing Observational
-
Study Aim:
To advance our understanding of Parkinson’s Disease and accelerate the development of advanced therapies to improve outcomes for patients.
-
Recruitment Target:
Ongoing patient recruitment of patient's diagnosed with Parkinson's Disease.
Speak to our study support specialist for more information on this study.
10 minutes to participate in this study
-
1
-
2
-
3
-
4
Step One
Practice - Choose a Study
uMed supports multiple studies sponsored by commercial and academic institutions.
Your practice can choose a study via our website or dedicated web application.
Step Two
Practice - Review & Approve Eligible Patients
uMed runs a study specific search to identify potential participants.
Previous
uMed searches are compatible with EMIS or SystmOne. The results of this search are available to your practice in our web application for sign-off.
Step Three
uMed - Patient Contact
Once approved, we manage patient contact on your behalf via SMS, email and/or letter.
Previous
We provide a dedicated study support line for all patient enquiries to minimise incoming calls to your practice.
For most studies, between 10-30% of patients engage with our outreach.
Step Four
Patient - Consents to Join Study
Congratulations! You've empowered your patients to participate in vital clinical research that is most relevant for them.
Previous
Once the study concludes, we will share results and patient feedback with you so that you can see the impact of your participation. Any revenue generated from commercial studies is shared with your practice.
What does the patient see?
We have built our process so that the patient experiences a seamless experience from the first text message they receive.
Not yet registered with uMed? Join over 400 GP Practices across the UK within the uMed Research Network and take part in the AccessPD study. Join the uMed Research Network.
More about AccessPD
AccessPD is a next generation research database and tissue bank (RTB) to advance our understanding of Parkinson’s Disease and accelerate the development of advanced therapies to improve outcomes for patients.
Register your interest in this study
Fill in the below form and a member of our team will be in touch to discuss next steps to participate in this study.